Search for: "ACTAVIS" Results 521 - 540 of 1,006
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
19 Dec 2019, 2:15 pm by Michael Carrier
The pharmaceutical industry presents some of the most important and challenging issues lying at the intersection of the patent and antitrust laws. [read post]
21 Nov 2018, 12:00 am by Alexa von Uexküll
In the UK cross-border case, the claimant Actavis was irrevocably bound to its undertaking not to challenge the validity of the Lilly patent. [read post]
25 Mar 2009, 12:17 pm
As we have reported previously, here, during the past year there have been other cGMP violations leading to generic drug recalls by Actavis, ETHEX / KV Pharmaceutical, and Sandoz / Novartis. [read post]
4 May 2012, 12:20 pm by Jeff Klein
That is, it is conceivable that Actavis could have taken additional steps consistent with the FDCA and the FDA approved label to impact the manner in which physicians prescribed metoclopramide (i.e., the “intended” use) and that a claim based on this failure to act may survive preemption under Mensing. [read post]
11 May 2009, 5:00 am
.; Actavis, Inc.; and Actavis Elizabeth LLC in Pennsylvania state court for injuries she allegedly suffered from the long-term ingestion of Reglan (or metoclopramide) as prescribed by her physician. [read post]
24 Mar 2022, 12:04 pm by Zak Gowen
Actavis, Inc., 570 U.S. 136 (2013), which held that such payments are unlawful when they are “large and unjustified. [read post]
18 Feb 2021, 1:40 pm by John Lewis
Defendants Actavis LLC and related entities (“Actavis”) and Shire together produce Intuniv’s generic counterpart. [read post]
4 Jun 2019, 3:59 am
  Jurisdictional battles in IP were confined to memories of Actavis v Lilly and pan-European DNIs, not, what is essentially, the scope of a damages inquiry. [read post]
21 Oct 2014, 7:20 am
Dynamite in-house faculty speakers – more than 20 of them − including Actavis, Biomet, Bard, GSK, du Pont, Endo, McKesson, Merck, Novo Nordisk, Olympus, Roche, and Teva. [read post]
17 Feb 2016, 12:19 am
 As the AmeriKat was busy getting to grips with Mr Justice Arnold's decision in the latest Lilly v Actavis case (see here), she relied on the talented (and ever succinct)  Eibhlin Vardy (A&O), to analyze the decision. [read post]
9 May 2013, 5:34 am
The lawsuit names Pfizer, as well as two different generic drug manufacturers - Actavis Elizabeth and Teva Pharmaceuticals - in the U.S. [read post]
2 Mar 2017, 6:00 am
" Here are some key findings: In 2016, 4,537 patent cases were filed -- a 22% decline from 2015 (5,819 cases) The Eastern District of Texas continues to lead the nation with 1,662 cases – nearly 37% of all cases filed, yet a 34% decrease over the district’s 2015 total (2,541 cases) This is the fourth year in a row that Judge Gilstrap had the most patent cases of any judge Samsung again leads LG Electronics and Apple as the most-sued patent defendant in 2016 Tech… [read post]
23 Aug 2016, 9:41 am
 | Judgement in Actavis v ICOS | Collective management of copyright for images displayed by search engines | Corporates and #Rio2016 | Global brandingNever too late 108 [week ending on Sunday 10 August] Limerick Competition - the results | UK finally speaks out about the "facts" of IP post Brexit| Is "Deadwood really cluttering up trade mark registers? [read post]
4 May 2019, 2:55 pm by Lawrence B. Ebert
Endo, 2017WL 3731001, at *14 (internal quotation marks omitted).Actavis argues that this limitation requires no constructionbecause of “[t]he plain language of the claims, and the undisputed chemical difference between 14-hydroxymorphinone [i.e., oxymorphone ABUK] and itshydrochloride salt. [read post]
7 Sep 2015, 10:01 am by Green and Associates
The lawsuit named Purdue Pharma (maker of OxyContin), Teva Pharmaceutical Industries, Janssen Pharmaceuticals – a subsidiary of Johnson & Johnson, Endo Health Solutions, and Actavis, as well as affiliated companies.One reason why the lawsuit was filed is that Purdue, which makes the best-selling painkiller OxyContin, has never gone to trial on a case of OxyContin abuse. [read post]
25 May 2018, 9:27 am
  Following on from the Warner-Lambert v Actavis [2015] EWHC 485 (Pat) (prescription by brand) Fujifilm v AbbVie [2017] EWHC 395 (Pat) (Arrow declaration) and Unwired Planet v Huawei [2017] EWHC 2988 (Pat) (global FRAND terms) decisions, this provides another example of the UK Patents Court providing highly specific and tailored relief appropriate to the facts of the case. [read post]